GILD
Gilead Sciences IncRecent alerts on GILD
All signals →
News
Tango Therapeutics Stock Is Up 840%, and This Fund Just Disclosed Buying $164 Million More
3d ago
News
Gilead's Hepcludex wins FDA approval for chronic HDV infection
10d ago
News
AbbVie, Merck, Astra among winners of EU drug recommendations this week
11d ago
News
Assembly Biosciences prices $100M equity offering
11d ago
News
A Healthy Return: Drug Spin-off Nets Keymed Up To $320M
14d ago
News
Software Slump Resumes, Bitcoin Plunges To $66,000: What's Moving Markets Wednesday?
14d ago
News
Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing
14d ago
News
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
14d ago
News
Biotech Sector May Flip to Market Leader by Year-End
14d ago
News
Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
14d ago
News
Kymera Revenue Drops 55 Percent in Q2
14d ago
News
MacroGenics Revenue Doubles in Q2
14d ago
News
IDEAYA (IDYA) Q2 Net Loss Improves 27%
14d ago
News
Tango (TNGX) Q2 Revenue Drops 52%
14d ago
News
Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales
14d ago
News
Why Gilead Scinces Stock Tumbled on Tuesday
14d ago
News
Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer
14d ago
News
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
14d ago
News
Gilead Sciences Beats Q4 EPS Forecast
14d ago
News
Why Gilead Sciences Stock Is Jumping Today
14d ago
News
Galapagos Unveils 2025 Split To Accelerate Innovation, Sharpen Strategic Focus
14d ago
News
Gilead Unveils Long-Term Data From Seladelpar In Patients With Rare Liver Disease
14d ago
News
After Failed Confirmatory Trial, Gilead Withdraws US Accelerated Approval Of Trodelvy As Bladder Cancer treatment
14d ago
News
Gilead Sciences/Merck's Investigational Once-Weekly HIV Combo Therapy Shows Sustained Virus Suppression To 48 Weeks
14d ago
News
Gilead Unveils 'Remarkable Outcomes' From Late-Stage Lenacapavir Study Showing Promise In Preventing HIV Infections
14d ago
Get push alerts for GILD
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS